Xiangyang Wang

Outlook Microsoft Office 365 Adobe Marketing Cloud Google Font API Google Tag Manager reCAPTCHA WordPress.org Mobile Friendly Remote AI

biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical drug development clinical trials oncology therapeutics egfr inhibitors antibody drug conjugates cancer treatment firmonertinib novel medicines regulatory approval treatment advances patient access expanded access policy strategic collaborations global development difficult-to-treat diseases innovation in biotech differentiated medicines clinical research partnerships commercialization drug candidate pipeline development cancer biology safety profiles efficacy profiles fda designation advanced cancers research collaborations anti-cancer therapies solid tumors preclinical studies phase 1 trials phase 2 trials phase 3 trials mutational targeting biologic rationale global health impact investment opportunities therapeutic development life sciences patient-centered care drug discovery pharmaceutical partnerships oncogene dependency market access strategies clinical efficacy health wellness & fitness hospital & health care